Sunanda Kane, MD, MSPH (National Chair)
Professor of Medicine
Mayo Clinic Rochester
Rochester, MN

Sasha Taleban, MD (Regional Chair)
Assistant Professor
Director, Inflammatory Bowel Disease (IBD) Program
University of Arizona
Tucson, AZ

Gary R. Lichtenstein, MD
Professor of Medicine
Director, IBD Center
University of Pennsylvania School of Medicine
Philadelphia, PA

Millie D. Long, MD, MPH
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
University of North Carolina
Chapel Hill, NC

Derek R. Patel, MD
Associate Clinical Services, Chief
Hillcrest Gastroenterology
San Diego, CA

Jointly Provided By

Activity Details

Credit Type: AMA PRA Category 1 Credit(s)
Credit Amount: 2.25 AMA PRA Category 1 Credit(s)
Release Date: January 12, 2017
Expiration Date: January 11, 2018
Estimated Time to Complete Activity: 2.25 hours
Registration Required: No
Fee for Activity: There is no fee for this educational activity.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Compare and contrast the clinical effects of the various IBD therapies
  2. Select individualized treatments for patients with IBD that maximize the opportunity to achieve remission and avoid relapse while minimizing toxicity
  3. Utilize available disease progression and drug monitoring strategies for patients with IBD
  4. Implement appropriate practice measures and quality of care process and outcomes measures in managing patients with IBD

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists and gastroenterology nurse practitioners (NPs) and physician assistants (PAs) who manage patients with IBD.

Requirements for Successful Completion




Disclosure of Conflicts of Interest

According to the disclosure policy of the University of Cincinnati, all faculty, planning committee members, and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interest related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence.

Disclosure will be made at the time of activity.

In accordance with the ACCME Standards for Commercial Support, the speakers for this course have been asked to disclose to participants the existence of any financial interest and/or relationship(s) (e.g., paid speaker, employee, paid consultant on a board, and/or committee for a commercial company) that would potentially affect the objectivity of his/her presentation or whose products or services may be mentioned during their presentation. The following disclosures were made:

Sunanda Kane, MD, MSPH, discloses the following relationships with commercial interests:

  • Advisory Board: 11 Health
  • Consultant: AbbVie, Samsung
  • Officer or Board Member: ACG, ABIM
  • Grant Recipient: UCB 

Sasha Taleban, MD, has no relevant relationships to disclose.

Gary R. Lichtenstein, MD, discloses the following relationships with commercial interests:

  • Consultant: Abbott/AbbVie, Actavis, Alaven, Hospira, Luitpold/American Regent, Pfizer Pharmaceuticals, Romark, Takeda
  • Consultant/Research: Celgene, Ferring, Janssen Biotech, Prometheus Laboratories, Receptos, Salix Pharmaceuticals/Valeant, Santarus, Shire Pharmaceuticals, UCB
  • Speaker for CME activities: Ironwood, Luitpold/American Regent
  • Editor (Honorarium): Clinical Advances in Gastroenterology, Gastro-Hep Communications, Springer Science and Business Media
  • Author (Honorarium): McMahon Publishing, Up-To-Date
  • Book Royalty: SLACK, Inc.

Millie D. Long, MD, MPH, discloses the following relationships with commercial interests:

  • Advisory Board: AbbVie, Pfizer, Takeda
  • Consultant: AbbVie, Takeda, Theravance
  • Research Support: Takeda
  • Speaker for CME activities: AbbVie

Derek R. Patel, MD, discloses the following relationships with commercial interests:

  • Speaker: AbbVie
  • Advisory Board: AbbVie

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Crohn’s & Colitis Foundation of America
Orna Ehrlich, MPH, has no relevant relationships to disclose.

RMEI Medical Education, LLC
Sherri Kramer, MD, has no relevant relationships to disclose.
Kyra Sheahan has no relevant relationships to disclose.
Faith Reidenbach has no relevant relationships to disclose.
Nora Hartley has no relevant relationships to disclose.

University of Cincinnati
Susan P. Tyler, MEd, CMP, CHCP, FACEHP, Director, has no relevant relationships to disclose.
Rick E. Ricer, MD, Professor Emeritus, has no relevant relationships to disclose.
Debora Cole, BS, Program Coordinator, has no relevant relationships to disclose.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, the Crohn’s & Colitis Foundation of America, and RMEI Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit

The University of Cincinnati designates this enduring material activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

By completing the curriculum challenge (at the beginning and again at the end of the activity), the pre-test, reviewing the course content, and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 2.25 AMA PRA Category 1 Credit™. A statement of credit will be available to print from your user history page.
Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.

Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

Statement of Commercial Support

This activity is supported by independent medical education grants from AbbVie, Celgene Corporation, Salix Pharmaceuticals, Takeda Pharmaceuticals U.S.A., Inc., and UCB, Inc.

Disclaimer Statement

The opinions expressed during the enduring material activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Off-label Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Contact Information for Questions about the Activity

Accreditation Support: Please contact the University of Cincinnati, Continuing Medical Education Department at or call 513-558-7277.

Technical Support: For any technical issues or issues with your CME Certificate, please visit:

Course Viewing Requirements

Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.